home.aspx
 
. https://pharmaceutical.report/Resources/Whitepapers/e73c3be0-c160-4400-be96-a5df7e34e125_Citeline Oncology Whitepaper_LR.pdf
whitepaper
A DECADE IN REVIEW: ONCOLOGY TRIAL BENCHMARKS AND SPONSOR ANALYSIS
The average cost of bringing a new drug to market continues to rise, with varying levels of investments across the highly competitive biopharmaceutical industry. To assess the potential effect of varying investments on trial activity and operations, this article reviews trial benchmarks within the active oncology therapeutic area. CHRISTINE BLAZYNSKI DOWNLOAD